Dataset Information

Proteomic profiling of bone marrow aspirate (BMA) samples collected pre-VD-CAG induction and post-induction VD-CAG-treated non-M3 AML

ABSTRACT: Proteomic profiling was performed by Novogene (Beijing, China), using data-independent acquisition (DIA) proteomics on paired bone marrow aspirate samples from 5 non-M3 AML patients before and after VD-CAG treatment. All patients achieved composite complete response (CRc) after 1 cycle of VD-CAG induction. Protein extraction, quantification, enzymatic digestion with trypsin (allowing up to 2 missed cleavage sites), desalting, and fractionation were conducted following standard protocols to ensure data quality at each step. Peptides were separated using nano-LC on a Vanquish Neo system and analyzed on an Orbitrap Astral high-resolution mass spectrometer, which features a quadrupole for precursor ion selection, an Orbitrap analyzer for high-dynamic-range HRAM spectra, and an Astral analyzer for high-sensitivity, up to 200 Hz HRAM spectral acquisition.

ORGANISM(S): Homo Sapiens

SUBMITTER: Yuping Gong

PROVIDER: PXD076348 | iProX | Mon Mar 30 00:00:00 BST 2026

REPOSITORIES: iProX

ACCESS DATA

Similar Datasets

Project description:We highlight the leap in performance made possible with new instrumentation in the Thermo Scientific Orbitrap Astral™ mass spectrometer. Integrated alongside a high-resolution accurate mass (HRAM) Orbitrap analyzer, the instrument introduces a fast-switching quadrupole mass filter congruent with downstream speeds of ion detection, a dual-pressure ion processor cell which fragments ions in the high-pressure cell before they are moved to the low-pressure cell for further accumulation and orthogonal extraction to the Astral analyzer, and a high dynamic range detector. Altogether, ions can be manipulated in five stages of the MS at once (Orbitrap, ion routing multipole, two ion processor stages, Astral analyzer), allowing for a high degree of parallelization which enables MS/MS scan speeds of 200 Hz while HRAM MS1 full scans are synchronously acquired in the Orbitrap analyzer. To provide such fast scan speeds, the Astral analyzer is capable of single-ion detection sensitivity like a linear ion trap, all while enabling resolving powers of 80,000 at m/z 524. Here, in triplicate 7-min microflow active LC gradients on the Orbitrap Astral MS, we report 7,852 protein groups from 94,267 peptides on average. When employing 15-, 30-, and 60-min active, nano-LC gradients, triplicate experiments yield an average of 9,831, 10,411, and 10,645 unique protein groups from 195,612, 234,406, and 245,754 unique peptides, respectively. These nanoflow methods delivered a median sequence coverage of 38%, 42.4% and 44.4% across identified proteins for each respective gradient length. Our 30-min method delivered approximately 347 proteins per minute. Finally, we applied our 30-min active gradient method to analyze a CRISPR-Cas9 knockout (KO) of the mitochondrial gene MGME1 in human HAP1 cells. There, we quantified an average of 10,353 proteins across three technical replicates and find 449 significantly up- or down-regulated proteins relative to wild-type (WT) HAP1 proteins. Proteins from the same sample quantified using a 61-min active gradient Orbitrap Ascend DIA method show strong fold-change correlations to and gene ontology (GO) term agreement with our results.Building upon the immense progress of the mass spectrometry and proteomics communities of the past ten years, here we report alongside other recent works, that the one-hour human proteome is now within reach.

Dataset Information

Proteomic profiling of bone marrow aspirate (BMA) samples collected pre-VD-CAG induction and post-induction VD-CAG-treated non-M3 AML

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets